Research Nurse Jennifer Cunningham, B.S.N., looks on as a healthy volunteer who receives an infusion of CIS43LS, an experimental monoclonal antibody against malaria, as part of Phase 1 clinical trial.

Read more about the study:

Public Domain Mark 1.0
Credit: National Institute of Allergy and Infectious Diseases, NIH

Leave a Reply

Your email address will not be published. Required fields are marked *